Climb Bio, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$67.9 | -$82.0 | -$40.3 | -$45.1 | -$35.7 |
| Net income | -$59.9 | -$73.9 | -$35.1 | -$45.2 | -$47.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$54.5 | -$15.6 | -$20.6 | — | — |
Shares outstanding 57.4M · Free float 53.8%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.